Tudor Investment Corp’s Ventyx Biosciences VTYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-583,611
Closed -$5.27M 4344
2025
Q4
$5.27M Buy
+583,611
New +$4.36M 0.01% 1119
2025
Q1
Sell
-17,780
Closed -$38.9K 3736
2024
Q4
$38.9K Sell
17,780
-2,575
-13% -$5.83K ﹤0.01% 2935
2024
Q3
$44.4K Sell
20,355
-7,778
-28% -$17.9K ﹤0.01% 2620
2024
Q2
$65K Buy
28,133
+8,790
+45% +$36.5K ﹤0.01% 2222
2024
Q1
$106K Sell
19,343
-19,235
-50% -$88K ﹤0.01% 2090
2023
Q4
$95.3K Buy
38,578
+32,613
+547% +$310K ﹤0.01% 2249
2023
Q3
$207K Sell
5,965
-23,271
-80% -$805K ﹤0.01% 2082
2023
Q2
$959K Buy
29,236
+4,888
+20% +$168K 0.01% 1340
2023
Q1
$816K Buy
+24,348
New +$947K 0.01% 1325
2022
Q4
Sell
-22,400
Closed -$782K 2892
2022
Q3
$782K Sell
22,400
-13,195
-37% -$292K 0.02% 1091
2022
Q2
$435K Buy
+35,595
New +$532K 0.01% 1351

Other funds holding VTYX

Tudor Investment Corp's VTYX Position: Q1 2026 in Review

Tudor Investment Corp sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 583,611 shares — an estimated $5.27M sold.

Tudor Investment Corp first reported a position in VTYX in Q2 2022 and held it in 11 quarters. The position peaked at $5.27M in Q4 2025. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

  • Tudor Investment Corp reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
  • Tudor Investment Corp sold 583,611 Ventyx Biosciences shares in Q1 2026, an estimated $5.27M.
  • Tudor Investment Corp first reported a position in Ventyx Biosciences in Q2 2022 and held it in 11 quarters.
  • Tudor Investment Corp's Ventyx Biosciences position peaked at $5.27M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.